developmental and epileptic encephalopathy, 25
developmental and epileptic encephalopathy, 25
Explore linked clinical trials. Standard reference: MONDO:00143923 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Intrathecal Gene Therapy For SLC13A5 Citrate Transporter Disorder | developmental and epileptic encephalopathy, 25 | Recruiting | Phase 1 / Phase 2 | 2026-06-30 | NCT07102524 | |
| SLC13A5 Deficiency Natural History Study - United States Only | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Rare Diseases, amelocerebrohypohidrotic syndrome, brain disorder, central nervous system disorder, developmental and epileptic encephalopathy, 25, epilepsy, hereditary disease, movement disorder, nervous system disorder | Enrolling by invitation | Not stated | 2025-08-05 | NCT06144957 | |
| SLC13A5 Deficiency Natural History Study - Remote Only | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Rare Diseases, amelocerebrohypohidrotic syndrome, brain disorder, central nervous system disorder, developmental and epileptic encephalopathy, 25, epilepsy, hereditary disease, movement disorder, nervous system disorder | Enrolling by invitation | Not stated | 2024-11-22 | NCT04681781 |